To date, a number of studies have identified associations between circulating C-reactive protein (CRP) levels and depression in individuals with obesity [81,82], suggesting that obesity-related pro-inflammatory pathways may play a mediating role in the underlying pathophysiology linking these diseases, including NAFLD. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.